X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (47) 47
humans (46) 46
hematology (36) 36
female (31) 31
male (31) 31
middle aged (31) 31
adult (24) 24
aged (20) 20
abridged index medicus (15) 15
adolescent (15) 15
oncology (15) 15
prognosis (14) 14
cancer (13) 13
remission induction (11) 11
young adult (11) 11
leukemia (10) 10
aged, 80 and over (9) 9
hemic and lymphatic diseases (8) 8
leukemia, myeloid, acute - drug therapy (8) 8
retrospective studies (8) 8
chemotherapy (7) 7
disease-free survival (7) 7
hematology, oncology and palliative medicine (7) 7
research (7) 7
treatment outcome (7) 7
classification (6) 6
disease (6) 6
karyotyping (6) 6
leukemia, myeloid, acute - mortality (6) 6
medicine, general & internal (6) 6
mutations (6) 6
recurrence (6) 6
risk factors (6) 6
survival (6) 6
acute myeloid-leukemia (5) 5
adults (5) 5
antineoplastic agents - therapeutic use (5) 5
cell line, tumor (5) 5
imatinib mesylate (5) 5
life sciences (5) 5
mutation (5) 5
patients (5) 5
poor-prognosis (5) 5
proportional hazards models (5) 5
risk (5) 5
survival analysis (5) 5
survival rate (5) 5
time factors (5) 5
transplantation (5) 5
acute lymphocytic leukemia (4) 4
acute myelogenous leukemia (4) 4
animals (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
benzamides (4) 4
care and treatment (4) 4
child (4) 4
colony-stimulating factor (4) 4
cytarabine (4) 4
diagnosis (4) 4
flow cytometry (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
genetics & heredity (4) 4
hematopoietic stem cell transplantation (4) 4
imatinib (4) 4
in situ hybridization, fluorescence (4) 4
intensive chemotherapy (4) 4
leukemia-lymphoma, adult t-cell - genetics (4) 4
lymphomas (4) 4
minimal residual disease (4) 4
mortality (4) 4
myelodysplastic syndromes (4) 4
phenotype (4) 4
physiological aspects (4) 4
precursor t-cell lymphoblastic leukemia-lymphoma - genetics (4) 4
pyrimidines - therapeutic use (4) 4
stem cell transplantation (4) 4
stem cells (4) 4
stem-cell transplantation (4) 4
therapy (4) 4
transplantation, homologous (4) 4
trial (4) 4
activation (3) 3
acute disease (3) 3
age (3) 3
age factors (3) 3
antimetabolites, antineoplastic - adverse effects (3) 3
antimetabolites, antineoplastic - therapeutic use (3) 3
antithymocyte globulin (3) 3
belgium (3) 3
biomarkers (3) 3
blood (3) 3
bone marrow (3) 3
children (3) 3
clinical trials (3) 3
combined modality therapy (3) 3
consolidation chemotherapy - methods (3) 3
cytarabine - administration & dosage (3) 3
cytogenetics (3) 3
cytosine-arabinoside (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 13, pp. 1189 - 1199
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1235 - 1248
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 31, pp. 3889 - +
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 11, pp. 1027 - 1036
Journal Article
Nature Genetics, ISSN 1061-4036, 06/2010, Volume 42, Issue 6, pp. 530 - 535
Journal Article
Journal Article
Genes Chromosomes and Cancer, ISSN 1045-2257, 04/2010, Volume 49, Issue 4, pp. 299 - 308
T-cell acute lymphoblastic leukemia (TALL) is the result of multiple oncogenic insults of thymocytes. Recently, new ABLI fusion genes have been identified that... 
CHRONIC MYELOGENOUS LEUKEMIA | AMPLIFICATION | ONCOLOGY | NUCLEAR-PORE | NUP214-ABL1 FUSION GENE | PHILADELPHIA-CHROMOSOME | GENETICS & HEREDITY | AMPLIFIED EPISOMES | BCR-ABL1 FUSION | ACTIVATION MECHANISM | ETV6-ABL TYROSINE KINASE | CHRONIC MYELOID-LEUKEMIA
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2019, Volume 116, Issue 13, pp. 6298 - 6307
Natural regulatory T cells (nTregs) ensure the control of self-tolerance and are currently used in clinical trials to alleviate autoimmune diseases and... 
Adenosine deaminase-binding CD26 | CD39 regulatory receptor | FOXP3 regulatory transcript | Microenvironmental cytokines | nTregs | ACTIVATION | TGF-BETA | adenosine deaminase-binding CD26 | TOLERANCE | MULTIDISCIPLINARY SCIENCES | ADENOSINE | ALPHA | microenvironmental cytokines | FOXP3 | TREGS | REGULATORY T-CELLS | GENERATION | DIFFERENTIATION | Interleukin-2 - metabolism | Cytokines - metabolism | Leukemia, Myeloid | Dendritic Cells - immunology | Humans | Autoimmune Diseases - immunology | Dipeptidyl Peptidase 4 - blood | Apyrase - blood | Cellular Microenvironment - immunology | T-Lymphocytes, Regulatory - immunology | Autoimmune Diseases - blood | CD4-Positive T-Lymphocytes - immunology | Dinoprostone - metabolism | Forkhead Transcription Factors - metabolism | Interleukin-10 - metabolism | Th17 Cells - immunology | Transforming Growth Factor beta - metabolism | T-Lymphocytes, Regulatory - physiology | Graft-versus-host reaction | CD26 antigen | Leukemia | Helper cells | Clinical trials | Prostaglandin E2 | Lymphocytes T | Blood | Inflammatory diseases | Plasticity (functional) | T-cell receptor | Cell activation | Interleukin 2 | Lymphocytes | Foxp3 protein | Bioindicators | Conditioning | Medical research | Memory cells | Maturation | Cytokines | Immunoregulation | Myeloid leukemia | Immunological tolerance | CD4 antigen | Hemopoiesis | Immune systems | Computer memory | Stem cells | Interleukin 10 | Biomarkers | Autoimmune diseases | Acute myeloid leukemia | Structure-function relationships | Index Medicus | Biological Sciences | PNAS Plus
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 2010, p. NA
Journal Article
Journal Article
Journal Article